Fig. 11From: Effects of dendritic core–shell glycoarchitectures on primary mesenchymal stem cells and osteoblasts obtained from different human donorsTEM images of a reference without nanoparticles, b PEI-25k-MAL-B treated cells, small structures (marked with arrows) sticking on the cell membrane can be seen c PEI-25k-MAL-B treated cells, endpoint 24 h, the arrows mark signs of mitochondrial destruction d PEI-5k-MAL-B treated samples, vesicular uptake of nanoparticles can be seenBack to article page